The Influence of Mild Hypothermia on the Pharmacokinetics and Time Course of Action of Neostigmine in Anesthetized Volunteers

Background The pharmacokinetics, maximum effect, and time course of action of neostigmine were studied in seven human volunteers. Methods Each volunteer was studied twice, during both normothermia and hypothermia. Anesthesia was induced with 30 &mgr;g/kg alfentanil and 3 mg/kg propofol, and was maintained with 60–70% nitrous oxide and 0.7–0.9% isoflurane. The mechanical response of the adductor pollicis to train-of-four stimulation of the ulnar nerve was recorded, and central body temperature maintained stable at either less than 34.5°C or greater than 36.5°C by surface cooling or warming. Before neostigmine administration, a stable 5% twitch height was obtained by an infusion of vecuronium, and the infusion rate remained unchanged thereafter. Neostigmine, 70 &mgr;g/kg, was then infused over 2 min, and blood samples for estimation of neostigmine concentrations were collected at intervals for 240 min. Results With hypothermia, the central volume of distribution of neostigmine decreased by 38%, and onset time of maximum effect increased (4.6 vs. 5.6 min). Hypothermia did not change the clearance (696 ml/min), maximum effect, or duration of action of neostigmine. Conclusions The efficacy of neostigmine as an antagonist of vecuronium-induced neuromuscular block is not altered by mild hypothermia.

[1]  J. Proost,et al.  Do Plasma Concentrations Obtained from Early Arterial Blood Sampling Improve Pharmacokinetic/Pharmacodynamic Modeling? , 1999, Journal of Pharmacokinetics and Biopharmaceutics.

[2]  L. Skovgaard,et al.  Pharmacokinetic studies of neuromuscular blocking agents: Good Clinical Research Practice (GCRP) , 2000, Acta anaesthesiologica Scandinavica.

[3]  P. White,et al.  Reversal of neuromuscular blockade. , 1998, Anesthesia and analgesia.

[4]  A. Mizisin,et al.  Effects of body and hindlimb temperature on laser Doppler blood flow and vascular conductance in rat sciatic nerve and skeletal muscle , 1997, Journal of the Neurological Sciences.

[5]  R. Miller,et al.  The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers. , 1994, The Journal of pharmacology and experimental therapeutics.

[6]  T. Heier,et al.  Mild intraoperative hypothermia increases duration of action and spontaneous recovery of vecuronium blockade during nitrous oxide-isoflurane anesthesia in humans. , 1991, Anesthesiology.

[7]  R. Miller,et al.  Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade? , 1990, Anesthesiology.

[8]  F. Donati,et al.  Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. , 1988, Anesthesiology.

[9]  R. Miller,et al.  Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection. , 1988, Journal of chromatography.

[10]  J. Mortola,et al.  Neonatal Pattern of Breathing Following Cesarean Section: Epidural versus General Anesthesia , 1983, Anesthesiology.

[11]  R. Miller,et al.  The Neuromuscular Pharmacology of Neostigmine in Infants and Children , 1983, Anesthesiology.

[12]  R. Miller,et al.  Antagonism of org NC 45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine. , 1982, British journal of anaesthesia.

[13]  D. Stanski,et al.  Pharmacokinetics of Edrophonium and Neostigmine When Antagonizing d‐Tubocurarine Neuromuscular Blockade in Man , 1981, Anesthesiology.

[14]  R. Cronnelly,et al.  Reversed-phase, ion-pair liquid chromatography of quaternary ammonium compounds: determination of pyridostigmine, neostigmine and edrophionium in biological fluids. , 1980, Journal of chromatography.

[15]  L. Sheiner,et al.  Renal Function and the Pharmacokinetics of Neostigmine in Anesthetized Man , 1979, Anesthesiology.

[16]  K. Muir,et al.  THE RELATIONSHIP BETWEEN THE PHARMACOKINETICS, CHOLINESTERASE INHIBITION AND FACILITATION OF TWITCH TENSION OF THE QUATERNARY AMMONIUM ANTICHOLINESTERASE DRUGS, NEOSTIGMINE, PYRIDOSTIGMINE, EDROPHONIUM AND 3‐HYDROXYPHENYLTRIMETHYLAMMONIUM , 1979, British journal of pharmacology.

[17]  R. Miller,et al.  Pancuronium-induced Neuromuscular Blockade, and Its Antagonism by Neostigmine, at 29, 37, and 41 C , 1977, Anesthesiology.

[18]  E. Eger,et al.  The effect of temperature on a d-tubocurarine neuromuscular blockade and its antagonism by neostigmine. , 1975, Journal of Pharmacology and Experimental Therapeutics.

[19]  E. Eger,et al.  Comparative Times to Peak Effect and Durations of Action of Neostigmine and Pyridostigmine , 1974, Anesthesiology.

[20]  B. Roufogalis,et al.  Effect of ligands on a discontinuous temperature dependence of the decarbamylation reaction of erythrocyte acetylcholinesterase. , 1973, Biochimica et biophysica acta.

[21]  Donaldson Ko,et al.  Chromatographic separation of the diastereoisomers of dl, L-5, 10-methylenetetrahydrofolate. , 1963 .

[22]  I B WILSON,et al.  Carbamyl derivatives of acetylcholinesterase. , 1961, The Journal of biological chemistry.